Top

17-08-2018 | Osteoarthritis | Review | Article

Efficacy of commonly prescribed analgesics in the management of osteoarthritis: a systematic review and meta-analysis

Journal: Rheumatology International

Authors: Mohan Stewart, Jolanda Cibere, Eric C. Sayre, Jacek A. Kopec

Publisher: Springer Berlin Heidelberg

Abstract

Objective

Pain management is a cornerstone of osteoarthritis (OA) management. The aim of this review is to obtain current, literature-based estimates of the effect of common pharmacologic treatments on pain reduction in OA.

Methods

A MEDLINE search (2006–2016) was conducted for randomized controlled trials studying acetaminophen, oral NSAIDs, topical NSAIDs, COX-2 inhibitors, and opioids in the treatment of OA pain. Drug effect on pain was estimated using relative change in pain, and expressed as percentage change. An overall effect for each drug category was obtained as a weighted average of study-specific effects, with weights based on each study’s sample size.

Results

Twenty-nine studies were included. The effect on pain was estimated in a total of 43 treatment arms (acetaminophen n = 6, oral NSAIDs n = 9, topical NSAIDs n = 8, COX-2 inhibitors n = 9, and opioids n = 11). Relative (%) changes in pain were found to be as follows: acetaminophen = 32.5, oral NSAIDs = 34.3, topical NSAIDs = 40.9, COX-2 inhibitors = 36.9, and opioids = 35.4.

Conclusion

The effects of 5 major drug categories in the treatment of OA pain were reviewed with data extracted from 29 studies published from 2006 to 2016. Acetaminophen was found to have an RC value close to that of oral NSAIDs. The effects of oral NSAIDs, COX-2 inhibitors, and opioids in controlling pain were similar to what has been demonstrated in previous literature. Topical NSAIDs were found to have a greater RC than oral NSAIDs.

Birtwhistle R, Morkem R, Peat G, Williamson T, Green ME, Khan S et al. (2015) Prevalence and management of osteoarthritis in primary care: an epidemiologic cohort study from the Canadian Primary Care Sentinel Surveillance Network. CMAJ Open 3:E270–E275CrossRef

MacDonald KV, Sanmartin C, Langlois K, Marshall DA (2014) Symptom onset, diagnosis and management of osteoarthritis. Health Rep 25:10–17PubMed

McAlindon TE, Bannuru RR, Sullivan MC, Arden NK, Berenbaum F, Bierma-Zeinstra SM et al. (2014) OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis Cartilage 22:363–388CrossRef

Hochberg MC, Altman RD, April KT, Benkhalti M, Guyatt G, McGowan J et al. (2012) American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res 64:465–474CrossRef

da Costa BR, Reichenbach S, Keller N, Nartey L, Wandel S, Jüni P et al. (2017) Effectiveness of non-steroidal anti-inflammatory drugs for the treatment of pain in knee and hip osteoarthritis: a network meta-analysis. Lancet 390:e21–e33CrossRef

Craig DGN, Bates CM, Davidson JS, Martin KG, Hayes PC, Simpson KJ (2012) Staggered overdose pattern and delay to hospital presentation are associated with adverse outcomes following paracetamol-induced hepatotoxicity: outcomes following staggered and delayed paracetamol overdose. Br J Clin Pharmacol 73:285–294CrossRef

Klinge SA, Sawyer GA (2013) Effectiveness and safety of topical versus oral nonsteroidal anti-inflammatory drugs: a comprehensive review. Phys Sportsmed 41:64–74CrossRef

Trelle S, Reichenbach S, Wandel S, Hildebrand P, Tschannen B, Villiger PM et al. (2011) Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis. BMJ 342:c7086CrossRef

Smith SR, Deshpande BR, Collins JE, Katz JN, Losina E (2016) Comparative pain reduction of oral non-steroidal anti-inflammatory drugs and opioids for knee osteoarthritis: systematic analytic review. Osteoarthritis Cartilage 24:962–972CrossRef

10.

Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJM, Gavaghan DJ et al. (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17:1–12CrossRef

11.

Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634CrossRef

12.

Suurmond R, van Rhee H, Hak T (2017) Introduction, comparison and validation of meta-essentials: a free and simple tool for meta-analysis. Res Synth Methods 8:537–553CrossRef

13.

Hawker GA, Mian S, Kendzerska T, French M (2011) Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF-36 BPS), and Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP). Arthritis Care Res 63(Suppl 11):S240–S252CrossRef

14.

Bellamy N (2002) WOMAC Osteoarthritis Index user guide. Version V. Brisbane (Australia): CONROD, The University of Queensland

15.

Elandt-Johnson RC, Johnson NL (1980) Survival models and data analysis. Wiley, New York

16.

Snedecor GW, Cochran WG (1980) Statistical methods, 7th edn. Iowa State University Press, Ames

17.

Cohen J (1988) Statistical power analysis for the behavioral sciences, 2nd edn. L. Erlbaum Associates, Hillsdale

18.

Higgins JPT, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539–1558CrossRef

19.

Prior MJ, Harrison DD, Frustaci ME (2014) A randomized, double-blind, placebo-controlled 12 week trial of acetaminophen extended release for the treatment of signs and symptoms of osteoarthritis. Curr Med Res Opin 30:2377–2387CrossRef

20.

Sadreddini S, Noshad H, Molaeefard M, Moloudi R, Ardalan MR, Ghojazadeh M (2009) A double blind, randomized, placebo controlled study to evaluate the efficacy of erythromycin in patients with knee effusion due to osteoarthritis. Int J Rheum Dis 12:44–51CrossRef

21.

Batlle-Gualda E, Román Ivorra J, Martín-Mola E, Carbonell Abelló J, Linares Ferrando LF, Tornero Molina J et al. (2007) Aceclofenac vs paracetamol in the management of symptomatic osteoarthritis of the knee: a double-blind 6-week randomized controlled trial. Osteoarthritis Cartilage 15:900–908CrossRef

22.

Herrero-Beaumont G, Ivorra JA, del Carmen Trabado M, Blanco FJ, Benito P, Martin-Mola E et al. (2007) Glucosamine sulfate in the treatment of knee osteoarthritis symptoms: a randomized, double-blind, placebo-controlled study using acetaminophen as a side comparator. Arthritis Rheum 56:555–567CrossRef

23.

Altman RD, Zinsenheim JR, Temple AR, Schweinle JE (2007) Three-month efficacy and safety of acetaminophen extended-release for osteoarthritis pain of the hip or knee: a randomized, double-blind, placebo-controlled study. Osteoarthritis Cartilage 15:454–461CrossRef

24.

Schnitzer TJ, Ekman EF, Spierings EL, Greenberg HS, Smith MD, Brown MT et al. (2015) Efficacy and safety of tanezumab monotherapy or combined with non-steroidal anti-inflammatory drugs in the treatment of knee or hip osteoarthritis pain. Ann Rheum Dis 74:1202–1211CrossRef

25.

Ekman EF, Gimbel JS, Bello AE, Smith MD, Keller DS, Annis KM et al. (2014) Efficacy and safety of intravenous tanezumab for the symptomatic treatment of osteoarthritis: 2 randomized controlled trials versus naproxen. J Rheumatol 41:2249–2259CrossRef

26.

Chiranthanut N, Hanprasertpong N, Teekachunhatean S (2014) Thai massage, and Thai herbal compress versus oral ibuprofen in symptomatic treatment of osteoarthritis of the knee: a randomized controlled trial. Biomed Res Int 2014:1–13CrossRef

27.

Balanescu AR, Feist E, Wolfram G, Davignon I, Smith MD, Brown MT et al. (2014) Efficacy and safety of tanezumab added on to diclofenac sustained release in patients with knee or hip osteoarthritis: a double-blind, placebo-controlled, parallel-group, multicentre phase III randomised clinical trial. Ann Rheum Dis 73:1665–1672CrossRef

28.

Baerwald C, Verdecchia P, Duquesroix B, Frayssinet H, Ferreira T (2010) Efficacy, safety, and effects on blood pressure of naproxcinod 750 mg twice daily compared with placebo and naproxen 500 mg twice daily in patients with osteoarthritis of the hip: a randomized, double-blind, parallel-group, multicenter study. Arthritis Rheum 62:3635–3644CrossRef

29.

Levy RM, Khokhlov A, Kopenkin S, Bart B, Ermolova T, Kantemirova R et al. (2010) Efficacy and safety of flavocoxid, a novel therapeutic, compared with naproxen: a randomized multicenter controlled trial in subjects with osteoarthritis of the knee. Adv Ther 27:731–742CrossRef

30.

Simon LS, Grierson LM, Naseer Z, Bookman AAM, Shainhouse ZJ (2009) Efficacy and safety of topical diclofenac containing dimethyl sulfoxide (DMSO) compared with those of topical placebo, DMSO vehicle and oral diclofenac for knee osteoarthritis. Pain 143:238–245CrossRef

31.

Pareek A, Chandanwale AS, Oak J, Jain UK, Kapoor S (2006) Efficacy and safety of aceclofenac in the treatment of osteoarthritis: a randomized double-blind comparative clinical trial versus diclofenac: an Indian experience. Curr Med Res Opin 22:977–988CrossRef

32.

Wadsworth LT, Kent JD, Holt RJ (2016) Efficacy and safety of diclofenac sodium 2% topical solution for osteoarthritis of the knee: a randomized, double-blind, vehicle-controlled, 4 week study. Curr Med Res Opin 32:241–250CrossRef

33.

Rother M, Conaghan PG (2013) A randomized, double-blind, phase III trial in moderate osteoarthritis knee pain comparing topical ketoprofen gel with ketoprofen-free gel. J Rheumatol 40:1742–1748CrossRef

34.

Conaghan PG, Dickson J, Bolten W, Cevc G, Rother M (2013) A multicentre, randomized, placebo- and active-controlled trial comparing the efficacy and safety of topical ketoprofen in Transfersome gel (IDEA-033) with ketoprofen-free vehicle (TDT 064) and oral celecoxib for knee pain associated with osteoarthritis. Rheumatology 52:1303–1312CrossRef

35.

Altman RD, Dreiser RL, Fisher CL, Chase WF, Dreher DS, Zacher J (2009) Diclofenac sodium gel in patients with primary hand osteoarthritis: a randomized, double-blind, placebo-controlled trial. J Rheumatol 36:1991–1999CrossRef

36.

Barthel HR, Haselwood D, Longley S, Gold MS, Altman RD (2009) Randomized controlled trial of diclofenac sodium gel in knee osteoarthritis. Semin Arthritis Rheum 39:203–212CrossRef

37.

Rother M, Lavins BJ, Kneer W, Lehnhardt K, Seidel EJ, Mazgareanu S (2007) Efficacy and safety of epicutaneous ketoprofen in Transfersome (IDEA-033) versus oral celecoxib and placebo in osteoarthritis of the knee: multicentre randomised controlled trial. Ann Rheum Dis 66:1178–1183CrossRef

38.

Yoo WH, Yoo HG, Park SH, Baek H, Lee YJ, Shim SC et al. (2014) Efficacy and safety of PG201 (Layla^®) and celecoxib in the treatment of symptomatic knee osteoarthritis: a double-blinded, randomized, multi-center, active drug comparative, parallel-group, non-inferiority, phase III study. Rheumatol Int 34:1369–1378CrossRef

39.

Ohtori S, Inoue G, Orita S, Takaso M, Eguchi Y, Ochiai N et al. (2013) Efficacy of combination of meloxicam and pregabalin for pain in knee osteoarthritis. Yonsei Med J 54[5]:1253–1258CrossRef

40.

Schnitzer TJ, Dattani ID, Seriolo B, Schneider H, Moore A, Tseng L et al. (2011) A 13-week, multicenter, randomized, double-blind study of lumiracoxib in hip osteoarthritis. Clin Rheumatol 30:1433–1446CrossRef

41.

DeLemos BP, Xiang J, Benson C, Gana TJ, Pascual MLG, Rosanna R et al. (2011) Tramadol hydrochloride extended-release once-daily in the treatment of osteoarthritis of the knee and/or hip: a double-blind, randomized, dose-ranging trial. Am J Ther 18:216–226CrossRef

42.

Bianchi M, Broggini M, Balzarini P, Franchi S, Sacerdote P (2007) Effects of nimesulide on pain and on synovial fluid concentrations of substance P, interleukin-6 and interleukin-8 in patients with knee osteoarthritis: comparison with celecoxib. Int J Clin Pract 61:1270–1277CrossRef

43.

Clegg DO, Reda DJ, Harris CL, Klein MA, O’Dell JR, Hooper MM et al. (2006) Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med 354:795–808CrossRef

44.

Spierings EL, Fidelholtz J, Wolfram G, Smith MD, Brown MT, West CR (2013) A phase III placebo- and oxycodone-controlled study of tanezumab in adults with osteoarthritis pain of the hip or knee. Pain 154:1603–1612CrossRef

45.

Fishman RL, Kistler CJ, Ellerbusch MT, Aparicio RT, Swami SS, Shirley ME et al. (2007) Efficacy and safety of 12 weeks of osteoarthritic pain therapy with once-daily tramadol (Tramadol Contramid OAD). J Opioid Manag 3:273–280CrossRef

46.

Gana TJ, Pascual ML, Fleming RR, Schein JR, Janagap CC, Xiang J et al. (2006) Extended-release tramadol in the treatment of osteoarthritis: a multicenter, randomized, double-blind, placebo-controlled clinical trial. Curr Med Res Opin 22:1391–1401CrossRef

47.

Machado GC, Maher CG, Ferreira PH, Pinheiro MB, Lin C-WC, Day RO et al. (2015) Efficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta-analysis of randomised placebo controlled trials. BMJ 350:h1225CrossRef

48.

Artus M, van der Windt DA, Jordan KP, Hay EM (2010) Low back pain symptoms show a similar pattern of improvement following a wide range of primary care treatments: a systematic review of randomized clinical trials. Rheumatology 49:2346–2356CrossRef

49.

Kopec JA, Sayre EC, Rahman M, Kang W, Finès P, Flanagan W et al. (2011) A simulation model of medication use and impact among persons with osteoarthritis in Canada [abstract]. J Rheumatol 38:1175

50.

Sarzi-Puttini P, Atzeni F, Lanata L, Bagnasco M (2013) Efficacy of ketoprofen vs. ibuprofen and diclofenac: a systematic review of the literature and meta-analysis. Clin Exp Rheumatol 31:731–738PubMed

51.

Sardana V, Burzynski J, Zalzal P (2017) Safety and efficacy of topical ketoprofen in transfersome gel in knee osteoarthritis: a systematic review. Musculoskeletal Care 15:114–121CrossRef

52.

Warner TD, Giuliano F, Vojnovic I, Bukasa A, Mitchell JA, Vane JR (1999) Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proc Natl Acad Sci USA 96:7563–7568CrossRef

53.

Drewes AM, Jensen RD, Nielsen LM, Droney J, Christrup LL, Arendt-Nielsen L et al. (2013) Differences between opioids: pharmacological, experimental, clinical and economical perspectives. Br J Clin Pharmacol 75:60–78CrossRef